25 XP   0   0   10

JENBURKT PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Let's analyse JENBURKT PHARMACEUTICALS LTD. together

PenkeI guess you are interested in JENBURKT PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of JENBURKT PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about JENBURKT PHARMACEUTICALS LTD.

I send you an email if I find something interesting about JENBURKT PHARMACEUTICALS LTD..

Quick analysis of JENBURKT PHARMACEUTICALS LTD. (30 sec.)










What can you expect buying and holding a share of JENBURKT PHARMACEUTICALS LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.60
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
INR277.32
Expected worth in 1 year
INR363.52
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR136.05
Return On Investment
20.2%

For what price can you sell your share?

Current Price per Share
INR672.40
Expected price per share
INR583.87 - INR714.75
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of JENBURKT PHARMACEUTICALS LTD. (5 min.)




Live pricePrice per Share (EOD)

INR672.40

Intrinsic Value Per Share

INR351.32 - INR414.55

Total Value Per Share

INR628.64 - INR691.87

2. Growth of JENBURKT PHARMACEUTICALS LTD. (5 min.)




Is JENBURKT PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$14.6m$14m$600.8k4.1%

How much money is JENBURKT PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money$2.9m$2.6m$277.1k9.4%
Net Profit Margin18.0%18.0%--

How much money comes from the company's main activities?

3. Financial Health of JENBURKT PHARMACEUTICALS LTD. (5 min.)




3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of JENBURKT PHARMACEUTICALS LTD.? (5 min.)

Welcome investor! JENBURKT PHARMACEUTICALS LTD.'s management wants to use your money to grow the business. In return you get a share of JENBURKT PHARMACEUTICALS LTD..

What can you expect buying and holding a share of JENBURKT PHARMACEUTICALS LTD.?

First you should know what it really means to hold a share of JENBURKT PHARMACEUTICALS LTD.. And how you can make/lose money.

Speculation

The Price per Share of JENBURKT PHARMACEUTICALS LTD. is INR672.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of JENBURKT PHARMACEUTICALS LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in JENBURKT PHARMACEUTICALS LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR277.32. Based on the TTM, the Book Value Change Per Share is INR21.55 per quarter. Based on the YOY, the Book Value Change Per Share is INR41.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR12.46 per quarter.
Based on historical numbers we can estimate the returns while holding a share of JENBURKT PHARMACEUTICALS LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.670.1%0.670.1%0.580.1%0.520.1%0.520.1%
Usd Book Value Change Per Share0.260.0%0.260.0%0.490.1%0.670.1%0.670.1%
Usd Dividend Per Share0.150.0%0.150.0%0.120.0%0.110.0%0.110.0%
Usd Total Gains Per Share0.410.1%0.410.1%0.620.1%0.770.1%0.770.1%
Usd Price Per Share7.99-7.99-6.80-5.89-5.89-
Price to Earnings Ratio11.94-11.94-11.66-11.24-11.24-
Price-to-Total Gains Ratio19.58-19.58-11.02-11.31-11.31-
Price to Book Ratio2.40-2.40-2.22-2.26-2.26-
Price-to-Total Gains Ratio19.58-19.58-11.02-11.31-11.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.0688
Number of shares123
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.150.11
Usd Book Value Change Per Share0.260.67
Usd Total Gains Per Share0.410.77
Gains per Quarter (123 shares)50.2095.01
Gains per Year (123 shares)200.81380.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
17412719153327370
2147254392105655750
32213825931589821130
429450979421013101510
536863699526316371890
6441763119631619652270
7515891139736822922650
85891018159842126203030
96621145179947329473410
107361272200052632753790

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%4.00.01.080.0%4.00.01.080.0%4.00.01.080.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%5.00.00.0100.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of JENBURKT PHARMACEUTICALS LTD.

About JENBURKT PHARMACEUTICALS LTD.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of JENBURKT PHARMACEUTICALS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit JENBURKT PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare JENBURKT PHARMACEUTICALS LTD. to the  industry mean.
  • A Net Profit Margin of 18.0% means that ₹0.18 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 18.0%. The company is making a huge profit. +2
  • The TTM is 18.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.0%TTM18.0%0.0%
TTM18.0%YOY18.0%0.0%
TTM18.0%5Y16.0%+2.0%
5Y16.0%10Y16.0%0.0%
1.1.2. Return on Assets

Shows how efficient JENBURKT PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare JENBURKT PHARMACEUTICALS LTD. to the  industry mean.
  • 17.4% Return on Assets means that JENBURKT PHARMACEUTICALS LTD. generated ₹0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 17.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 17.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.4%TTM17.4%0.0%
TTM17.4%YOY15.6%+1.8%
TTM17.4%5Y16.0%+1.3%
5Y16.0%10Y16.0%0.0%
1.1.3. Return on Equity

Shows how efficient JENBURKT PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare JENBURKT PHARMACEUTICALS LTD. to the  industry mean.
  • 20.1% Return on Equity means JENBURKT PHARMACEUTICALS LTD. generated ₹0.20 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 20.1%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 20.1%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ20.1%TTM20.1%0.0%
TTM20.1%YOY19.0%+1.1%
TTM20.1%5Y20.0%+0.1%
5Y20.0%10Y20.0%0.0%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of JENBURKT PHARMACEUTICALS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient JENBURKT PHARMACEUTICALS LTD. is operating .

  • Measures how much profit JENBURKT PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare JENBURKT PHARMACEUTICALS LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y6.8%-6.8%
5Y6.8%10Y6.8%0.0%
1.2.2. Operating Ratio

Measures how efficient JENBURKT PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.04 means that the operating costs are ₹1.04 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 1.036. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.036. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.036TTM1.0360.000
TTM1.036YOY1.054-0.018
TTM1.0365Y1.090-0.054
5Y1.09010Y1.0900.000
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of JENBURKT PHARMACEUTICALS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if JENBURKT PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 5.14 means the company has ₹5.14 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 5.145. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.145. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.145TTM5.1450.000
TTM5.145YOY3.567+1.578
TTM5.1455Y4.331+0.813
5Y4.33110Y4.3310.000
1.3.2. Quick Ratio

Measures if JENBURKT PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare JENBURKT PHARMACEUTICALS LTD. to the  industry mean.
  • A Quick Ratio of 4.31 means the company can pay off ₹4.31 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 4.307. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.307. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.307TTM4.3070.000
TTM4.307YOY2.667+1.640
TTM4.3075Y3.442+0.865
5Y3.44210Y3.4420.000
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of JENBURKT PHARMACEUTICALS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of JENBURKT PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare JENBURKT PHARMACEUTICALS LTD. to industry mean.
  • A Debt to Asset Ratio of 0.14 means that JENBURKT PHARMACEUTICALS LTD. assets are financed with 13.7% credit (debt) and the remaining percentage (100% - 13.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 0.137. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.137. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.137TTM0.1370.000
TTM0.137YOY0.179-0.042
TTM0.1375Y0.195-0.058
5Y0.19510Y0.1950.000
1.4.2. Debt to Equity Ratio

Measures if JENBURKT PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare JENBURKT PHARMACEUTICALS LTD. to the  industry mean.
  • A Debt to Equity ratio of 15.9% means that company has ₹0.16 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The MRQ is 0.159. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.159. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.159TTM0.1590.000
TTM0.159YOY0.218-0.059
TTM0.1595Y0.245-0.087
5Y0.24510Y0.2450.000
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of JENBURKT PHARMACEUTICALS LTD.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings JENBURKT PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare JENBURKT PHARMACEUTICALS LTD. to the  industry mean.
  • A PE ratio of 11.94 means the investor is paying ₹11.94 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The EOD is 12.060. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.945. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.945. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.060MRQ11.945+0.115
MRQ11.945TTM11.9450.000
TTM11.945YOY11.663+0.282
TTM11.9455Y11.242+0.703
5Y11.24210Y11.2420.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The EOD is 19.853. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 19.664. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 19.664. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD19.853MRQ19.664+0.189
MRQ19.664TTM19.6640.000
TTM19.664YOY40.975-21.311
TTM19.6645Y21.294-1.630
5Y21.29410Y21.2940.000
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of JENBURKT PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 2.40 means the investor is paying ₹2.40 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of JENBURKT PHARMACEUTICALS LTD.:

  • The EOD is 2.425. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.402. Based on the equity, the company is underpriced. +1
  • The TTM is 2.402. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.425MRQ2.402+0.023
MRQ2.402TTM2.4020.000
TTM2.402YOY2.215+0.186
TTM2.4025Y2.258+0.144
5Y2.25810Y2.2580.000
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of JENBURKT PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--21.55021.5500%41.218-48%55.464-61%55.464-61%
Book Value Per Share--277.320277.3200%255.770+8%218.152+27%218.152+27%
Current Ratio--5.1455.1450%3.567+44%4.331+19%4.331+19%
Debt To Asset Ratio--0.1370.1370%0.179-23%0.195-30%0.195-30%
Debt To Equity Ratio--0.1590.1590%0.218-27%0.245-35%0.245-35%
Dividend Per Share--12.46212.4620%10.198+22%8.908+40%8.908+40%
Eps--55.75655.7560%48.584+15%43.167+29%43.167+29%
Free Cash Flow Per Share--33.86933.8690%13.829+145%26.691+27%26.691+27%
Free Cash Flow To Equity Per Share--33.86933.8690%13.829+145%20.916+62%20.916+62%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--414.554--------
Intrinsic Value_10Y_min--351.319--------
Intrinsic Value_1Y_max--31.931--------
Intrinsic Value_1Y_min--31.027--------
Intrinsic Value_3Y_max--103.264--------
Intrinsic Value_3Y_min--97.395--------
Intrinsic Value_5Y_max--183.427--------
Intrinsic Value_5Y_min--167.824--------
Market Cap--2939257800.0002939257800.0000%2600571043.700+13%2229104920.360+32%2229104920.360+32%
Net Profit Margin--0.1800.1800%0.1800%0.160+13%0.160+13%
Operating Margin----0%-0%0.068-100%0.068-100%
Operating Ratio--1.0361.0360%1.054-2%1.090-5%1.090-5%
Pb Ratio2.425+1%2.4022.4020%2.215+8%2.258+6%2.258+6%
Pe Ratio12.060+1%11.94511.9450%11.663+2%11.242+6%11.242+6%
Price Per Share672.400+1%666.000666.0000%566.650+18%490.820+36%490.820+36%
Price To Free Cash Flow Ratio19.853+1%19.66419.6640%40.975-52%21.294-8%21.294-8%
Price To Total Gains Ratio19.770+1%19.58119.5810%11.021+78%11.312+73%11.312+73%
Quick Ratio--4.3074.3070%2.667+61%3.442+25%3.442+25%
Return On Assets--0.1740.1740%0.156+11%0.160+8%0.160+8%
Return On Equity--0.2010.2010%0.190+6%0.200+1%0.200+1%
Total Gains Per Share--34.01234.0120%51.416-34%64.372-47%64.372-47%
Usd Book Value--14686764.00014686764.0000%14085900.000+4%11896996.800+23%11896996.800+23%
Usd Book Value Change Per Share--0.2590.2590%0.495-48%0.666-61%0.666-61%
Usd Book Value Per Share--3.3283.3280%3.069+8%2.618+27%2.618+27%
Usd Dividend Per Share--0.1500.1500%0.122+22%0.107+40%0.107+40%
Usd Eps--0.6690.6690%0.583+15%0.518+29%0.518+29%
Usd Free Cash Flow--1793700.0001793700.0000%761604.000+136%1455640.800+23%1455640.800+23%
Usd Free Cash Flow Per Share--0.4060.4060%0.166+145%0.320+27%0.320+27%
Usd Free Cash Flow To Equity Per Share--0.4060.4060%0.166+145%0.251+62%0.251+62%
Usd Market Cap--35271093.60035271093.6000%31206852.524+13%26749259.044+32%26749259.044+32%
Usd Price Per Share8.069+1%7.9927.9920%6.800+18%5.890+36%5.890+36%
Usd Profit--2952840.0002952840.0000%2675664.000+10%2353776.000+25%2353776.000+25%
Usd Revenue--16409904.00016409904.0000%14847804.000+11%14671447.200+12%14671447.200+12%
Usd Total Gains Per Share--0.4080.4080%0.617-34%0.772-47%0.772-47%
 EOD+2 -4MRQTTM+0 -0YOY+26 -85Y+27 -810Y+27 -8

3.2. Fundamental Score

Let's check the fundamental score of JENBURKT PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.060
Price to Book Ratio (EOD)Between0-12.425
Net Profit Margin (MRQ)Greater than00.180
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.307
Current Ratio (MRQ)Greater than15.145
Debt to Asset Ratio (MRQ)Less than10.137
Debt to Equity Ratio (MRQ)Less than10.159
Return on Equity (MRQ)Greater than0.150.201
Return on Assets (MRQ)Greater than0.050.174
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of JENBURKT PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.859
Ma 20Greater thanMa 50673.110
Ma 50Greater thanMa 100667.695
Ma 100Greater thanMa 200696.274
OpenGreater thanClose675.100
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
Net Interest Income  28,1902,90631,0964,69335,7893,58139,370-43,040-3,670



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,418,121
Total Liabilities194,224
Total Stockholder Equity1,223,897
 As reported
Total Liabilities 194,224
Total Stockholder Equity+ 1,223,897
Total Assets = 1,418,121

Assets

Total Assets1,418,121
Total Current Assets810,906
Long-term Assets810,906
Total Current Assets
Cash And Cash Equivalents 36,599
Short-term Investments 509,232
Net Receivables 169,616
Inventory 83,376
Other Current Assets 8,639
Total Current Assets  (as reported)810,906
Total Current Assets  (calculated)807,462
+/- 3,444
Long-term Assets
Intangible Assets 1,874
Long-term Assets Other 120,233
Long-term Assets  (as reported)607,214
Long-term Assets  (calculated)122,107
+/- 485,107

Liabilities & Shareholders' Equity

Total Current Liabilities157,618
Long-term Liabilities36,606
Total Stockholder Equity1,223,897
Total Current Liabilities
Short Long Term Debt 24,410
Accounts payable 60,968
Other Current Liabilities 12,055
Total Current Liabilities  (as reported)157,618
Total Current Liabilities  (calculated)97,433
+/- 60,185
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt4,886
Long-term Liabilities  (as reported)36,606
Long-term Liabilities  (calculated)4,886
+/- 31,720
Total Stockholder Equity
Retained Earnings 1,131,050
Total Stockholder Equity (as reported)1,223,897
Total Stockholder Equity (calculated)1,131,050
+/- 92,847
Other
Capital Stock44,133
Common Stock Shares Outstanding 4,413
Net Invested Capital 1,248,307
Net Working Capital 653,288



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
1,028,249
1,040,698
1,203,800
1,429,491
1,418,121
1,418,1211,429,4911,203,8001,040,6981,028,24900
   > Total Current Assets 
638,859
659,216
896,680
895,427
799,261
759,042
810,906
810,906759,042799,261895,427896,680659,216638,859
       Cash And Cash Equivalents 
0
0
12,268
25,340
24,937
50,314
36,599
36,59950,31424,93725,34012,26800
       Short-term Investments 
0
0
510,977
520,179
413,722
415,545
509,232
509,232415,545413,722520,179510,97700
       Net Receivables 
119,366
147,670
256,457
222,801
140,007
152,068
169,616
169,616152,068140,007222,801256,457147,670119,366
       Inventory 
107,457
68,044
98,312
108,987
75,815
98,877
83,376
83,37698,87775,815108,98798,31268,044107,457
       Other Current Assets 
8,411
28,226
13,767
13,304
11,692
60
8,639
8,6396011,69213,30413,76728,2268,411
   > Long-term Assets 
0
0
131,570
145,272
404,587
670,449
607,214
607,214670,449404,587145,272131,57000
       Property Plant Equipment 
104,981
94,491
104,216
110,032
0
0
0
000110,032104,21694,491104,981
       Goodwill 
0
0
14
14
14
0
0
0014141400
       Intangible Assets 
0
0
11,490
8,414
4,797
3,056
1,874
1,8743,0564,7978,41411,49000
       Long-term Assets Other 
0
0
0
0
910
113,097
120,233
120,233113,0979100000
> Total Liabilities 
0
0
253,594
240,655
219,138
255,666
194,224
194,224255,666219,138240,655253,59400
   > Total Current Liabilities 
182,957
130,694
226,156
198,008
179,262
212,798
157,618
157,618212,798179,262198,008226,156130,694182,957
       Short Long Term Debt 
0
0
74,693
34,389
37,106
58,152
24,410
24,41058,15237,10634,38974,69300
       Accounts payable 
60,162
41,221
65,490
52,264
36,122
71,104
60,968
60,96871,10436,12252,26465,49041,22160,162
       Other Current Liabilities 
54,394
83,376
77,743
85,778
10,640
11,522
12,055
12,05511,52210,64085,77877,74383,37654,394
   > Long-term Liabilities 
0
0
27,440
42,647
39,876
42,868
36,606
36,60642,86839,87642,64727,44000
       Capital Lease Obligations Min Short Term Debt
0
0
0
17,409
13,563
9,397
4,886
4,8869,39713,56317,409000
       Long-term Liabilities Other 
0
0
27,440
29,084
0
0
-1
-10029,08427,44000
> Total Stockholder Equity
0
0
774,655
800,043
984,662
1,173,825
1,223,897
1,223,8971,173,825984,662800,043774,65500
   Common Stock
46,493
46,493
45,894
45,894
0
0
0
00045,89445,89446,49346,493
   Retained Earnings Total Equity0000000
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
7,404
518
1,142
-23,396
0
0
0
000-23,3961,1425187,404



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue1,367,492
Cost of Revenue-330,044
Gross Profit1,037,4481,037,448
 
Operating Income (+$)
Gross Profit1,037,448
Operating Expense-1,086,407
Operating Income281,085-48,959
 
Operating Expense (+$)
Research Development12,259
Selling General Administrative234,716
Selling And Marketing Expenses0
Operating Expense1,086,407246,975
 
Net Interest Income (+$)
Interest Income40,199
Interest Expense-3,670
Other Finance Cost-40,199
Net Interest Income-3,670
 
Pretax Income (+$)
Operating Income281,085
Net Interest Income-3,670
Other Non-Operating Income Expenses0
Income Before Tax (EBT)328,647281,085
EBIT - interestExpense = -3,670
246,070
249,740
Interest Expense3,670
Earnings Before Interest and Taxes (EBIT)0332,317
Earnings Before Interest and Taxes (EBITDA)354,908
 
After tax Income (+$)
Income Before Tax328,647
Tax Provision-82,577
Net Income From Continuing Ops246,070246,070
Net Income246,070
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net03,670
 

Technical Analysis of JENBURKT PHARMACEUTICALS LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of JENBURKT PHARMACEUTICALS LTD.. The general trend of JENBURKT PHARMACEUTICALS LTD. is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine JENBURKT PHARMACEUTICALS LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of JENBURKT PHARMACEUTICALS LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 696.50 < 705.00 < 714.75.

The bearish price targets are: 595.64 > 586.90 > 583.87.

Tweet this
JENBURKT PHARMACEUTICALS LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of JENBURKT PHARMACEUTICALS LTD.. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

JENBURKT PHARMACEUTICALS LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of JENBURKT PHARMACEUTICALS LTD.. The current macd is 2.95404862.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the JENBURKT PHARMACEUTICALS LTD. price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for JENBURKT PHARMACEUTICALS LTD.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the JENBURKT PHARMACEUTICALS LTD. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
JENBURKT PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) ChartJENBURKT PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of JENBURKT PHARMACEUTICALS LTD.. The current adx is 19.23.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell JENBURKT PHARMACEUTICALS LTD. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
JENBURKT PHARMACEUTICALS LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of JENBURKT PHARMACEUTICALS LTD.. The current sar is 698.01.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
JENBURKT PHARMACEUTICALS LTD. Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of JENBURKT PHARMACEUTICALS LTD.. The current rsi is 50.86. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
JENBURKT PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) ChartJENBURKT PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of JENBURKT PHARMACEUTICALS LTD.. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the JENBURKT PHARMACEUTICALS LTD. price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
JENBURKT PHARMACEUTICALS LTD. Daily Stochastic Oscillator ChartJENBURKT PHARMACEUTICALS LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of JENBURKT PHARMACEUTICALS LTD.. The current cci is -1.93292742.

JENBURKT PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) ChartJENBURKT PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of JENBURKT PHARMACEUTICALS LTD.. The current cmo is 0.65554352.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
JENBURKT PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) ChartJENBURKT PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of JENBURKT PHARMACEUTICALS LTD.. The current willr is -48.7854251.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that JENBURKT PHARMACEUTICALS LTD. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
JENBURKT PHARMACEUTICALS LTD. Daily Williams %R ChartJENBURKT PHARMACEUTICALS LTD. Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of JENBURKT PHARMACEUTICALS LTD..

JENBURKT PHARMACEUTICALS LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of JENBURKT PHARMACEUTICALS LTD.. The current atr is 25.08.

JENBURKT PHARMACEUTICALS LTD. Daily Average True Range (ATR) ChartJENBURKT PHARMACEUTICALS LTD. Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of JENBURKT PHARMACEUTICALS LTD.. The current obv is 12,783.

JENBURKT PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) ChartJENBURKT PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of JENBURKT PHARMACEUTICALS LTD.. The current mfi is 64.75.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
JENBURKT PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) ChartJENBURKT PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for JENBURKT PHARMACEUTICALS LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-07-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-07-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-07-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-08-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-08-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-08-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-08-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-08-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-08-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-08-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-08-31STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-09-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-09-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-09-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-09-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-09-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-09-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-10-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-10-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-31MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

JENBURKT PHARMACEUTICALS LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of JENBURKT PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.859
Ma 20Greater thanMa 50673.110
Ma 50Greater thanMa 100667.695
Ma 100Greater thanMa 200696.274
OpenGreater thanClose675.100
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of JENBURKT PHARMACEUTICALS LTD. with someone you think should read this too:
  • Are you bullish or bearish on JENBURKT PHARMACEUTICALS LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about JENBURKT PHARMACEUTICALS LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about JENBURKT PHARMACEUTICALS LTD.

I send you an email if I find something interesting about JENBURKT PHARMACEUTICALS LTD..


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about JENBURKT PHARMACEUTICALS LTD..

Receive notifications about JENBURKT PHARMACEUTICALS LTD. in your mailbox!